Ocugen Reports Progress in Q1 2025 with Advancements in Gene Therapy
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its first-quarter 2025 financial results and shared updates on its growing pipeline of gene therapy treatments aimed at combating significant unmet …
Ocugen Reports Progress in Q1 2025 with Advancements in Gene Therapy Read More